Overview

• Tribunal judiciaire de Vienne ruled the family’s civil complaint inadmissible due to insufficient evidence linking Théo’s birth defects to glyphosate exposure.
• The court highlighted the absence of invoices or records to confirm Sabine Grataloup’s use of Glyper herbicide during her 2006 pregnancy.
• Bayer-Monsanto’s defense argued that Glyper was manufactured by Italian firm Novafito and denied any causal responsibility for Théo’s malformations.
• Regulatory authorities such as INRS, EFSA and ECHA have maintained that glyphosate shows no teratogenic effects at non-toxic exposure levels.
• The Grataloup family, whose son endured 55 surgeries for severe esophageal and tracheal malformations, plans to appeal and continue seeking accountability.